Incidence of Pancreatic Malignancy and Thyroid Neoplasm in Type 2 Diabetes Mellitus Patients who Initiate Exenatide Compared to Other Antihyperglycemic Drugs - Phase 2 (Extended Accrual and Follow-Up)

06/07/2016
02/07/2024
EU PAS number:
EUPAS13956
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Redacted protocol BO15

English (746.88 KB - PDF) View document
Study results
Study results

D5550R00003 (EUPAS13956) Revised Final Report 17APR2018_AZ_Redacted

English (4.07 MB - PDF) View document
Study report
Other information